首页> 外文OA文献 >LIN9 and NEK2 Are Core Regulators of Mitotic Fidelity That Can Be Therapeutically Targeted to Overcome Taxane Resistance

【2h】

LIN9 and NEK2 Are Core Regulators of Mitotic Fidelity That Can Be Therapeutically Targeted to Overcome Taxane Resistance

机译：Lin9和Nek2是有丝分裂保真度的核心调节因子，可以治疗旨在克服紫杉烷抗性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Melyssa S. Roberts; Jennifer M. Sahni; Morgan S. Schrock; Katrina M. Piemonte; Kristen L. Weber-Bonk; Darcie D. Seachrist; Stefanie Avril; Lindsey J. Anstine; Salendra Singh; Steven T. Sizemore; Vinay Varadan; Matthew K. Summers; Ruth A. Keri;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
专利

1. LIN9 and NEK2 Are Core Regulators of Mitotic Fidelity That Can Be Therapeutically Targeted to Overcome Taxane Resistance [J] . Intelligence: A Multidisciplinary Journal . 2020,第期

机译：LIN9和NEK2是有丝分裂保真度的核心调节器，可以治疗旨在克服紫杉烷抗性
2. LIN9 and NEK2 Are Core Regulators of Mitotic Fidelity That Can Be Therapeutically Targeted to Overcome Taxane Resistance [J] . Roberts Melyssa S., Sahni Jennifer M., Schrock Morgan S., Cancer research: The official organ of the American Association for Cancer Research, Inc . 2020,第8期

机译：Lin9和Nek2是有丝分裂保真度的核心调节因子，可以治疗旨在克服紫杉烷抗性
3. Therapeutic Melting Pot of Never in Mitosis Gene A Related Kinase 2 (Nek2):A Perspective on Nek2 as an Oncology Target and Recent Advancements in Nek2 Small Molecule Inhibition [J] . Brendan Frett, Robert V. Brown, Mingliang Ma, Journal of Medicinal Chemistry . 2014,第14期

机译：从未有丝分裂基因A相关激酶2（Nek2）的治疗性熔炉：Nek2作为肿瘤学靶标和Nek2小分子抑制的最新进展的观点
4. Targeting fatty acid synthase to inhibit tumor growth and overcome taxane resistance [C] . Joshua J. Souchek, Lindsey Muraskin, Lucas Houser, Visualizing and Quantifying Drug Distribution in Tissue III . 2019

机译：靶向脂肪酸合酶以抑制肿瘤生长并克服紫杉烷抗性
5. Targeting mechanisms of resistance to taxane-based chemotherapy. [D] . Huang, Chung-Ying. 2008

机译：对紫杉烷类化学疗法耐药的靶向机制。
6. PRC2 targeting is a therapeutic strategy for EZ score defined high-risk multiple myeloma patients and overcome resistance to IMiDs [O] . Laurie Herviou, Alboukadel Kassambara, Stéphanie Boireau, 2018

机译：PRC2靶向是EZ评分定义的高危多发性骨髓瘤患者的治疗策略可克服对IMiD的耐药性
7. PRC2 targeting is a therapeutic strategy for EZ score defined high-risk multiple myeloma patients and overcome resistance to IMiDs [O] . Laurie Herviou, Alboukadel Kassambara, Stéphanie Boireau, 2018

机译：PRC2靶向是EZ评分的治疗策略，定义了高风险多发性骨髓瘤患者，克服对IMID的抗性

LIN9 and NEK2 Are Core Regulators of Mitotic Fidelity That Can Be Therapeutically Targeted to Overcome Taxane Resistance

著录项

引文网络

相似文献

相关主题

期刊订阅